All News
All news
-
News CPHI Webinar Series - Pharma Action Against COVID-19 – Listen Now
Listen to recordings of all webinars broadcast during the week of May 04-08 -
News Sai Life Sciences joins the global ‘COVID Moonshot’ project
Sai Life Sciences, today announced its collaboration with the COVID Moonshot project that aims to deliver an antiviral drug candidate effective against COVID-19. With an in-kind contribution of a team of Medicinal Chemists and supporting infrastr... -
News COVID-19 VACCINE DEVELOPMENT
Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across th... -
News Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home? -
News Evonik launches European API manufacturing capacity expansion programme
EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity -
News Gilead outlines plans for global expansion of remdesivir production
Biotech in discussions with pharmaceutical and chemical manufacturers on how to broaden supply of antiviral that last week received an emergency use authorization for treatment of COVID-19 from the FDA -
News Wasdell makes multimillion-pound investment in new packaging equipment
The contract packaging company has plans to install new equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity. -
News Bio-Rad launches anti-certolizumab pegol antibodies
Using this critical antibody reagent at the preclinical stage of development will minimize the need to revalidate assays with different reagents at the clinical development stage. -
News I Holland ‘Play it Again’ with webinar series
By bringing tabletting knowledge to home offices and desk tops, the company encourages its customer to stay safe and stay skilled. -
News Univercells launches new subsidiary called Univercells Technologies
The new business unit will focus on existing automated biomanufacturing products, as well as launching new technologies. -
News RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED DEVICE
RetroNose is a completely new drug delivery concept to dispense drug formulation to the nasal cavity. The principle of this concept is to deliver a spray through the oral cavity to deposit the drug in the nasal cavity from rear to front. To avoid... -
News Collaboration on track to develop new antibiotic resistance technology
The system has the potential to revolutionise the turnaround time for the assessment of suspected UTIs and reduce the use of antibiotics. -
News Sartorius closes acquisition of selected assets of Danaher Life Sciences
The addition of various laboratory and bioprocessing technologies will support customers to develop biotech medicines and vaccines. -
News Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus
Collaboration leverages CDMO’s expertise in tech transfer and manufacturing to aim for 1 million doses per day -
News Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19
As biopharma searches for vaccines and treatments to alleviate the crisis, how can companies manage shortened timelines to rapidly develop and manufacture safe and effective products on a global scale? A recent Endpoints webinar sheds some light -
News Catalent to manufacture J&J's lead COVID-19 vaccine candidate
Collaboration includes joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity. -
News Kedrion and Kamada partner up for anti-COVID-19 IgG product
Human plasma-derived product will be developed and manufactured utilizing Kamada’s proprietary IgG platform technology -
News Strides starts exports of generic version of Avigan for COVID-19 treatment
Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM -
News Tjoapack secures investment to increase pharma packaging capabilities
The CPO has immediate plans to expand its automated packaging capabilities, including for injectable products. -
News Wasdell acquires specialist packaging supplier
The acquisition will strengthen Wasdell’s capabilities and product offerings, including 100% recyclable and biodegradable options, in the medical device sector. -
News New technologies for solid dosage forms from Syntegon
Syntegon's new coater series can handle tablets with highly potent active ingredients. -
News Johnson & Johnson signs up Emergent BioSolutions to support COVID-19 vaccine manufacturing
CDMO to supply drug substance manufacturing services and reserve capacity for possible commercial production next year -
News Catalent Biologics completes $14 million commercial packaging expansion
The expansion includes three high-speed packaging lines — a syringe assembly machine, an auto-injector assembly machine and a top-load cartoner. -
News Diamond Pharma Services' acquisition strengthens pharmacovigilance division
The acquisition will enhance senior-level expertise, which will support clients from Diamond’s regulatory affairs business in specialist areas such as gene and cell therapies. -
News AAALAC International renews full accreditation to Sai Life Sciences for its laboratory animal care and use program
As a validation of our commitment to maintaining the highest standards in animal care and compliance with industry and regulatory guidelines, the Sai Life Sciences discovery facility in Pune recently received a renewed accreditation for its labo... -
News Responding to the COVID-19 pandemic
Since the outbreak of the COVID-19, Sai Life Sciences has been taking several proactive measures to protect its employees and their families, and to minimize the impact on its partners, customers and the community. -
News Moehs Quality
The Quality policy of MOEHS is based in the cGMP international for Active Pharmaceutical Ingredients (API) manufacturers. These are CFR 210-211 and ICHQ7 guide. Different MOEHS factories are regularly inspected by the local authorities and the FDA.In a... -
News May 4-8: CPHI Webinar Series - Pharma Action Against COVID-19
The pharmaceutical events world doesn't have to stop for coronavirus. Join us for expert insight and analysis on how pharma is responding to the COVID-19 pandemic in several key areas. -
News Innovative medical cannabis packaging
Whatever the dosage of medical cannabis, Sanner offers a range of reliable and safe packaging formats. -
News 2020 CPHI Pharma Awards are open for entries
Submit your entry before 1 July 2020! -
News CPHI & P-MEC China moves to December to enable international attendance
Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition. -
News Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion
Second 140,000 square-foot facility is expected to open next year -
News IQVIA Market Report 2018-2022: Thailand
IQVIA and CPHI are pleased to bring you our special Market Prognosis Report, providing an overview of the Thai pharma market, 2018-2022. -
News How is the Pharma industry adjusting to the impact of COVID-19 on global exhibitions?
Trade shows and exhibitions are key platforms for buyers and sellers of pharmaceutical ingredients, products and solutions to meet, network and do business. With the exhibitions industry having to adapt quickly to the fallout of COVID-19, what's th... -
News Drug export bans and stockpiling causing problems for globally-focused pharma distributors, says EFPIA
Decisions by individual European countries to ensure medicines availability during the COVID-19 pandemic are complicating international supply chains, industry association says -
News For the second year KOLINPHARMA® is on the FT1000 - Europe's Fastest Growing Companies
KOLINPHARMA® ranks 359th in the fourth edition of the FT1000 2020 Europe's Fastest Growing Companies of the Financial Times.
-
News Hovione's 'world's first' innovative inhaler receives prestigious design award
The 8Shot DPI is capable of delivering high doses of drug to the lungs. -
News The future of liquid pharmaceutical processing on show ... virtually!
Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety. -
News New agile solutions to accelerate digital supply chain transformation
New solutions will provide critical transparency to the life sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply. -
News Quality system at MOEHS GROUP
The Quality policy of MOEHS is based in the cGMP international for Active Pharmaceutical Ingredients (API) manufacturers. These are CFR 210-211 and ICHQ7 guide. Different MOEHS factories are regularly inspected by the local authorities and the FDA. ... -
News How drug delivery and device manufacturers can capitalise on the biologics boom
The biologics market is Pharma’s fastest growing market. With such significant growth of a different breed of products, what are the opportunities and implications for pharma packaging and drug delivery manufacturers? -
News Market leading content at Pharmapack Europe 2020
Pharmapack Europe offers a content programme which covers the latest packaging developments, opportunities and regulatory changes affecting both major and developing markets. -
News Nitrosamine contamination: pharma’s re-evaluation of its supply chain
The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API manufacturers who need to perform risk evaluations of their processes -
News Indian hydroxychloroquine and paracetamol exports decided on case-by-case basis, says Pharmexcil
Importing countries’ embassies are being asked to submit detailed requests for the key medicines amid COVID-19 pandemic -
News Fujifilm ramps up Avigan production as Japanese government stockpiles potential COVID-19 therapy
Japanese drugmaker plans to meet 100,000 treatment course target by July -
News Lupin receives FDA all-clear for Mandideep API manufacturing facility
Company becomes the fourth Indian pharma firm to secure FDA clearance in the last two weeks -
News Sanofi and GSK announce COVID-19 vaccine partnership
Companies to combine innovative technologies to develop an adjuvanted coronavirus vaccine -
News Inno4Life B.V. joins the Swiss Dec Group
Dec Group announces the acquisition of Inno4Life. -
News Alfa Laval launches the first premium separator system for single-use biopharma processing
The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material. -
News Nektium's botanical ingredient Zynamite granted US patent for brain-enhancing activities
Zynamite is an all-natural evidence-based nootropic and sports performance ingredient, supported by clinical studies. -
News Romaco completes virtual FAT for a blister machine
Despite current travel restrictions, the machine manufacturer manages to perform factory acceptance tests (FATs) via a live stream at its manufacturing facility. -
News AstraZeneca "incredibly excited" by lung cancer treatment trial
Independent Data Monitoring Committee (IDMC) recommends unblind Phase III trial of Tagrisso 2 years ahead of schedule. -
News Blockchain could galvanize COVID-19 impacted healthcare supply chains: GlobalData
Blockchain technology could prove to be the missing link for global healthcare supply chains exposed by the COVID-19 pandemic in building resilience and galvanizing efficiency, transparency and authenticity, according to market research firm, GlobalDat... -
News BERG named visionary in first-ever Frost Radar AI in Drug Discovery report
The biotech pioneer is one of the first companies to develop corporate partnerships in this application of artificial intelligence (AI) for drug discovery. -
News Making sanitizers available during COVID-19 outbreak
Over the past few weeks since the outbreak of COVID-19, there’s been a sudden rise in sanitization efforts by various public and private organizations to help arrest the spread of the disease. This, along with efforts of individuals in their own spaces... -
News Sai Life Sciences becomes first India-HQ company to join PSCI
Sai Life Sciences, today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’. -
News Just the right dosage!
How exactly should laundry detergent be dosed so that the laundry is completely clean, without the environment suffering? Does the dishwasher detergent compartment have to be filled completely in order to achieve streak-free cleanliness? -
News German pharma companies are meeting the corona "stress test"
The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications. -
News Novel transfection reagent set to alleviate viral vector bottleneck
The FectoVIR-AAV transfection reagent achieves large-scale transient transfection resulting in up to a 10-fold increase in AAV functional viral titer yields in suspension cell systems. -
News India says shipments of hydroxychloroquine will resume after US exerts pressure
Move comes 24 hours after US President warns of "retaliation" if export ban was not lifted -
News Evotec expands into gene therapy with new Austrian unit
Evotec has established a dedicated gene therapy-based R&D site in Orth an der Donau, Austria with the immediate focus of spearheading a partnership with Japan’s Takeda to support its research projects, the German drug discovery firm said Monday. -
News Servier strengthens its R&D pipeline with Symphogen acquisition
Symphogen becomes the antibody center of excellence within Servier. -
News World’s leading biobanks join a global network to advance personalized healthcare research
The platform enables collaboration between pharmaceutical institutions, healthcare and academic researchers to generate valuable insights and advance medical research. -
News Fully automated gluing and casting of medical devices
The medical technology industry is growing faster than other industries and is currently experiencing a real change: more and more innovative products are being developed to help patients and relieve the burden on the healthcare system in the lon... -
News KOLINPHARMA® obtains the patent in the United States of America for IVUXUR® - 17/6/2019
This is a further confirmation of the commitment of KOLINPHARMA® aimed at protecting and enhancing the know-how and investments made in R&D. -
News Chinese CDMOs legislating for the future
The Chinese pharmaceutical CDMO sector is set for rapid expansion, thanks to major amendments to the country's Drug Administration Law that make outsourcing manufacturing easier -
News FDA orders ranitidine withdrawal due to nitrosamine contamination risk
US drug regulator, the Food and Drug Administration, has ordered the immediate withdrawal of all prescription and over-the-counter versions of heartburn drug, ranitidine – commonly known as Zantac – after concluding certain products may pre... -
News FDA launches programme to speed up development of COVID-19 treatments
The US Food and Drug Administration said Tuesday it is “using every tool at the agency’s disposal” with the launch of a new program to speed up the development of treatments for patients with COVID-19. -
News China focused on meeting international API demand amid pandemic, say officials
Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article. -
News The Future of Medicine: What are the therapies of tomorrow?
As biopharma heads towards a new decade, extracting value from innovation remains a key theme in medicines development. However, rather than accepting the traditional model of novel treatments via the R&D pipeline as the innovative focus, the industry ... -
News China focused on meeting international API demand amid pandemic, say officials
China is stepping up its efforts to produce and ship active pharmaceutical ingredients (APIs), with a focus on meeting international demand, particularly for those showing potential to treat the COVID-19 disease, according to Chinese officials on Tuesd... -
News CDMO Ritedose chooses ChargePoint to ensure drug substance mixing process sterility
The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process. -
News European patent granted for amatoxin conjugates for tumor therapy
The patent covers the crosslinking of certain carrier molecules, for example, antibodies, via specific binding sites to amatoxins. -
News New blood test able to detect 50 cancer types
Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located. -
News New device offers a convenient way to monitor compressed air for viable particles
Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device. -
News PandemiCam — our greatest chance yet to detect, monitor and beat COVID-19?
Joint venture between Spinview and VR Media Technology creates device that provides accurate and fast detection of infectious people with far greater clarity than any single parameter test available today. -
News EMA to only issue electronic medicines certificates during COVID-19 pandemic
The European Medicines Agency (EMA) said Monday it will only issue electronically signed and authenticated certificates for human and veterinary medicines in place of printed ones so it can continue to provide the documents during the COVID-19 pandemic... -
News CDMO Suven’s finished drug exports halted due to Indian COVID-19 lockdown
Indian contract development and manufacturing organisation, Suven Pharmaceuticals, has warned it cannot export finished products due to a shortage of raw materials following the country’s recent lockdown to fight the COVID-19 pandemic. -
News WOMEN IN PHARMA LEADERSHIP -- Senior Leaders Advise We Must Think More Human to Retain Top Female Talent in Pharma.
The Women in Leadership Forum is a networking and knowledge-sharing event for pharma executives to share experiences and strategies for bringing diversity and equal opportunities to the industry. -
News Innovative Salts for Biopharma
With more than 130 years of experience, Dr. Paul Lohmann® is an expert in salt manufacturing and provides DPL-BioPharm Salts for the biopharmaceutical industry. -
News Alvotech and DKSH partner to bring key biosimilar to Asia
Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide. -
News Positive update on the development of new XF‐platform drug formulations
Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections. -
News ProBioGen selected for development and large-scale manufacturing services
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development. -
News How did the Indian Pharma Market Achieve Self-Sufficiency?
A look at how India has achieved pharmaceutical self-sufficiency over the years - taking steps to become a global leader not only in the production of low-cost generic medicines but increasingly, end-to-end drug discovery and development. -
News Lonza's new medium boosts and optimizes AAV production in insect cells
The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies. -
News Helsinn receives European approval of its IV formulation of Akynzeo
The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose. -
News Biologics: The Driving Force for CDMOs
CDMOs build capacity to capitalise on biologics boom -
News Global API Snapshot: Pharma Demands and Evolving Markets
Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout. -
News Generics Boom: Growing Global Demand Reshaping Sector
Despite consolidation, competition between manufacturers is fierce and the generic drug market continues to grow. -
News FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment
Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO. -
News Oxford Biomedica signs LSA with Juno Therapeutics
Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday. -
News Univercells launches new cell and gene focused CDMO Exothera
A new contract development and manufacturing organisation to support cell and gene developers with process development and production of viral vectors has been launched by bioprocessing provider Univercells. -
News Smart Packaging: Adding Value and Enhancing the Patient Experience
The ability of pharmaceutical packaging solutions to add value and improve the experience for both patients and healthcare professionals was a core theme at Pharmapack Europe 2020, with an emphasis on how the industry can identify opportunities via tec... -
News What Impact will Coronavirus have on Pharma Supply Chains?
The worldwide inter-dependency of pharmaceutical manufacturing is highlighted by the ongoing Coronavirus situation. How can the global supply of diagnostic kits, drugs, medical supplies, and equipment be sustained to treat patients in the face of suppl... -
News WOMEN IN PHARMA LEADERSHIP -- Leadership Lessons: How empathy can inspire great leadership
Recognizing the importance of empathetic leadership to business growth and sustainability -
News Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site
Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday. -
News CPHI announces new pharma events calendar for 2020
Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19. -
News Vaxxas HD-MAP to deliver vaccines directly to the skin
Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch. -
News Haselmeier receives medical device Master File Number for its injection pen systems
This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development. -
News FDA grants EUA to Thermo Fisher’s diagnostics test for coronavirus
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s diagnostic test for coronavirus, the contract development and manufacturing organisation said Monday. -
News Technique improves drug delivery system characterization
Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems. -
News Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19
The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients. -
News Contec launches virtual training tool sensitive to social distancing
A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations. -
News Artificial Intelligence: Moving beyond efficiency gains in drug development
Is the pharma industry making the most of AI’s potential when it comes to accelerating and enhancing pharmaceutical drug development? -
News Indian pharma supply chain disruption could surpass 2017 if COVID-19 not contained within three months: Ind-Ra
Indian pharmaceutical supply chain disruption could be far greater than the China environmental regulation-induced shortfall of 2017 If the COVID-19 outbreak is not contained within the next three months, credit ratings agency India Ratings and Researc... -
News CPHI Annual Report 2019
New modalities, new methods and new thinking to solve old problems -
News Leadership change at Fujifilm Diosynth Biotechnologies as Meeson appointed CEO
Japanese bio-focused CDMO Fujifilm Diosynth Biotechnologies has announced a change of leadership with president and COO, Martin Meeson taking over as CEO, replacing Steve Bagshaw, who is retiring. -
News Unlocking the potential of cannabinoid-derived drugs
Following the 2018 FDA approval of GW Pharmaceuticals’ Epidiolex®, there has been increased interest in the development of cannabinoid-derived drug substances for innovative new therapies. We examine the state of the market and future potenti... -
News Looking beyond the one-stop-shop hype: what's driving the CDMO market
Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts. -
News Mylan launches first bioequivalent alternative to Advair Diskus in Canada
Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate". -
News FDA approves Pharming's new facility for expanded Ruconest production
Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita... -
News Sartorius simplifies biologics production with new bioreactor
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform. -
News Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial
Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint. -
News Nanoform and Orion collaborate on 'nanoformed' APIs
Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges. -
News Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility
CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide. -
News Sai Life Sciences SCM shines with awards in Supply Risk and Supplier Relationship Management
Sai Life Sciences won two awards at the recently concluded 2nd SCMPro India Procurement Leadership Forum & Awards 2020, in the categories of Supply Risk Management and Supplier Relationship Management. -
News Sai Life Sciences receives ISO 14001:2015 and ISO 45001:2018 certification
Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office. -
News Systech International to be Acquired by Dover Corporation
Systech International (“Systech”) announced today that it has entered into a definitive agreement to be acquired by Dover Corporation. -
News FLAVOXALE® - a unique ingredient from Disproquima
FLAVOXALE® is a unique ingredient derived from the combination of an exclusive propolis extract (M.E.D. propolis), manuka honey and manuka essential oil. -
News Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven
Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance